Enasidenib mesylate
Enasidenib mesylate (AG-221 mesylate) is a potent and selective IDH2 mutase inhibitor that promotes differentiation of leukemia myeloid cells for the treatment of acute myeloid leukemia.
Product Specifications
CAS Number
1650550-25-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
569.48
Molecular Formula
C20H21F6N7O4S
Notes
Research use only, not for human use.
Receptor
Dehydrogenase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog